New FDA Lab Art in Architecture

Agency:
State: Colorado
Level of Government: Federal
Category:
  • A - Research and development
  • B - Special Studies and Analyses - Not R&D
  • Z - Maintenance, Repair or Alteration of Real Property
Opps ID: NBD00159532296208205
Posted Date: Mar 23, 2023
Due Date: May 19, 2023
Solicitation No: FDAAIA2023
Source: Members Only
New FDA Lab Art in Architecture
Active
Contract Opportunity
Notice ID
FDAAIA2023
Related Notice
Department/Ind. Agency
General Information
  • Contract Opportunity Type: Special Notice (Updated)
  • All Dates/Times are: (UTC-06:00) MOUNTAIN STANDARD TIME, DENVER, USA
  • Updated Published Date: Mar 23, 2023 08:24 am MDT
  • Original Published Date: Feb 28, 2023 11:30 am MST
  • Updated Response Date: May 19, 2023 05:00 pm MDT
  • Original Response Date: Mar 31, 2023 05:00 pm MDT
  • Inactive Policy: Manual
  • Updated Inactive Date: May 20, 2023
  • Original Inactive Date: Apr 01, 2023
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code:
  • NAICS Code:
  • Place of Performance:
    Lakewood , CO 80225
    USA
Description

The General Services Administration (GSA) Art in Architecture Program commissions American artists (citizens and Lawful Permanent Residents or Permanent Workers of the United States) to create publicly scaled and permanently installed artworks for Federal buildings nationwide. GSA announces an opportunity for a federal art commission in conjunction with a new construction project for the Food and Drug Administration (FDA) at the Denver Federal Center in Lakewood, Colorado.


Attachments/Links
Contact Information
Primary Point of Contact
Secondary Point of Contact
History

Related Document

Feb 28, 2023[Special Notice (Original)] New FDA Lab Art in Architecture

TRY FOR FREE

Not a USAOPPS Member Yet?

Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.

Start Free Trial Today >